A European, observational, three-year cohort comparative study on the safety of the fixed-dose combination pravastatin 40 mg/fenofibrate 160 mg (Pravafenix) versus statin alone in real clinical practice (POSE) First published 29/07/2016 Last updated 05/09/2023 EU PAS number:EUPAS13661 Study Finalised